Contributors
Dr Neil Aaronson
The Netherlands Cancer Institute, Amsterdam, The Netherlands
Dr Giovanni Apolone
Mario Negri Institute, Milano, Italy
Paulo Carita
Sanofi-Aventis, Bagneux, France
Dr Olivier Chassany
Hôpital St Louis, Paris, France
Katrin Conway
Mapi Research Institute & Mapi Research Trust, Lyon, France
Dr. Dominique Dubois
Johnson & Johnson Pharmaceutical Services, Beerse, Belgium
Kirsten Gertsen
NV Organon, Oss, The Netherlands
Dr Asha Hareendran
Pfizer, Sandwich, UK
Bernard Jambon
Mapi Group, Lyon, France
Dr Fred Jost
F. Hoffman-La Roche Ltd, Basel Switzerland
Paul Kind
University of York, UK
Dr Patrick Marquis
Mapi Values, Boston, MA, USA
Dr Pauline McNulty
Johnson and Johnson, Raritan, NJ, USA
Dr Carolin Miltenburger
Schering AG, Berlin, Germany
Dr Elizabeth Piault
Mapi Values, Boston, MA, USA
Dr Margaret Rothman
Johnson and Johnson, Raritan, NJ, USA
Dr Pierre-Philippe Sagnier
Bayer PLC, Uxbridge, UK
Prof. Marianne Sullivan
Sahlgrenska University Hospital, Göteborg, Sweden
Dr. Maria Watson
GlaxoSmithKline, RTP, NC, USA
Dr Anders Ingelgard
AstraZeneca r&D, Moelndal, Sweden
Dr York Zoellner
Solvay Pharmaceuticals GmbH, Hannover, Germany